论文部分内容阅读
目的:探讨奥扎格雷钠联合胞磷胆碱钠片治疗急性脑梗塞的疗效及康复护理措施。方法:将90例急性脑梗塞患者随机分为对照组和治疗组,各45例。对照组应用红花黄色素氯化钠注射液100mg加入0.9%氯化钠溶液250ml静脉输入,每日1次,连用15d;治疗组应用奥扎格雷钠氯化钠注射液240mg加入0.9%氯化钠溶液250ml静脉输入,1次/d,胞磷胆碱钠片每次0.2g,3次/d,15d为1个疗程。观察两组的临床疗效以及治疗前后神经功能缺损(NDS)评分和日常生活能力(ADL)评分,并进行对比。结果:治疗组总显效率和总有效率明显高于对照组(P<0.05或P<0.01);两组治疗前NDS评分和ADL评分无明显差异,治疗后治疗组明显优于对照组(P<0.05或P<0.01)。结论:奥扎格雷钠联合胞磷胆碱钠片治疗配以正确的康复及护理措施,能显著改善急性脑梗塞患者的神经功能和日常生活能力,提高临床疗效,值得推广运用。
Objective: To investigate the efficacy of ozagrel combined with citicoline sodium in the treatment of acute cerebral infarction and its nursing measures. Methods: 90 patients with acute cerebral infarction were randomly divided into control group and treatment group, 45 cases each. The control group, safflower yellow sodium chloride injection 100mg 0.9% sodium chloride solution 250ml intravenously once daily for 15d; the treatment group with sodium ozagrel sodium and sodium chloride injection 240mg 0.9% chlorinated Sodium 250ml intravenous infusion, 1 / d, citicoline sodium tablets 0.2g each time, 3 times / d, 15d for a course of treatment. The clinical efficacy and the scores of NDS and ADL before and after treatment were observed and compared. Results: The total effective rate and total effective rate in the treatment group were significantly higher than those in the control group (P <0.05 or P <0.01). There was no significant difference between the two groups before treatment and the ADL score. After treatment, the treatment group was significantly better than the control group (P <0.05 or P <0.01). Conclusion: Ozagrel sodium combined with citicoline sodium tablets combined with correct rehabilitation and nursing measures can significantly improve the patients with acute cerebral infarction neurological function and daily living ability, improve clinical efficacy, it is worth promoting the use of.